phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Depressive Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JC; Chen, TC; Hong, WC; Lin, YT; Yeh, TS; Yu, YL | 1 |
1 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Depressive Disorder
| Article | Year |
|---|---|
NPFFR2 Activates the HPA Axis and Induces Anxiogenic Effects in Rodents.
Topics: Adrenal Cortex Hormones; Animals; Anxiety; Corticotropin-Releasing Hormone; Depressive Disorder; Hydrazines; Hypothalamo-Hypophyseal System; Hypothalamus; Mice; Oligopeptides; Peptide Fragments; Rats; Receptors, Neuropeptide | 2017 |